You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023160010
Dec 20233604
Jan 20242902
Feb 20243401
Mar 20244602
Apr 20242401
May 20242200
Jun 20242000
Jul 20241802
Aug 20241201
Sep 20241403
Oct 20241203
Nov 20244809
Dec 20241203
Jan 20251205
Feb 2025403
Mar 2025002
Apr 2025005
May 2025003
Jun 2025005
Total503064